Gene Editing: The Future of Genomic Medicine & Biotech Investing

FromGoldman Sachs Exchanges

Start listening View podcast show

Gene Editing: The Future of Genomic Medicine & Biotech Investing

FromGoldman Sachs Exchanges

ratings:

Length:

18 minutes

Released:

Mar 23, 2022

Format:

Podcast episode

Description

In the latest episode of Exchanges at Goldman Sachs, Salveen Richter, Lead Analyst for the U.S. Biotechnology Sector in Goldman Sachs Research, explains how new innovations in gene editing are transforming the future of medicine and the greater biotech investment landscape.

Released:

Mar 23, 2022

Format:

Podcast episode

Titles in the series (100)

In each episode of "Exchanges at Goldman Sachs," people from the firm share their insights on developments shaping industries, markets and the global economy.

Skip carousel

Narrowing the Jobs Gap: An exchange on technology and work by Goldman Sachs Exchanges
29 min listen
Taxes, Trade and More in a Trump Presidency: On the economic agenda of America's next president by Goldman Sachs Exchanges
38 min listen
A Revolution in Cancer Treatment: An exchange on some of the latest developments in healthcare by Goldman Sachs Exchanges
13 min listen
The Global Growth Landscape: An exchange on developments influencing global growth by Goldman Sachs Exchanges
18 min listen
The Future of the US-China Economic Relationship: An exchange on the US-China investment relationship by Goldman Sachs Exchanges
26 min listen
Artificial Intelligence: The Next Wave of Disruption: An exchange on the economic potential of Growth Markets around the world by Goldman Sachs Exchanges
18 min listen
A Conversation with Lloyd Blankfein: An exchange on key themes for the global economy by Goldman Sachs Exchanges
30 min listen
Planes, Brains and Automobiles: The Future of Innovation: An exchange on industry-disrupting innovations by Goldman Sachs Exchanges
19 min listen
Mutant Mosquitoes, 'Peak Stuff' and the Shifting Currents of Innovation: An exchange on the sharing economy, drones and more by Goldman Sachs Exchanges
20 min listen
The Business Case for Climate Action: An exchange on the Paris climate agreement and turning global urgency into action by Goldman Sachs Exchanges
27 min listen
Global Equity Markets in Flux: An exchange with our president and chief operating officer by Goldman Sachs Exchanges
22 min listen
Brexit: After the Vote: An exchange on Brexit by Goldman Sachs Exchanges
28 min listen
Cord Cutting Goes Prime Time: An exchange on the way we watch by Goldman Sachs Exchanges
25 min listen
Brittle Markets: The Risks from Falling Liquidity: An exchange on market liquidity by Goldman Sachs Exchanges
26 min listen
China, Trump and Asia's Shifting Trade Order: What Trump means for Asia by Goldman Sachs Exchanges
23 min listen
Charting the Course for a Stronger South Africa: An exchange on South Africa and the broader region by Goldman Sachs Exchanges
24 min listen
The Future of Finance: An exchange on the way we pay, lend and bank by Goldman Sachs Exchanges
30 min listen
Revitalizing Communities Through Impact Investing: An exchange on impact investing by Goldman Sachs Exchanges
19 min listen
Half Full: The Case for Remaining Invested in US Equities: Why there's reason to be optimistic about US equities by Goldman Sachs Exchanges
29 min listen
The State of the Markets: Gary Cohn on Interest Rates, Liquidity and Risk Management: An exchange with our president and chief operating officer by Goldman Sachs Exchanges
25 min listen
Tax Reform, Bitcoin and the Year Ahead for Financials: On the state of the financial industry heading into 2018 by Goldman Sachs Exchanges
29 min listen
The UK Macro Environment: An exchange on the growth outlook in the UK by Goldman Sachs Exchanges
13 min listen
The Digitization of Finance: An exchange on tech and finance by Goldman Sachs Exchanges
27 min listen
Beyond the Fed Hike: The Business of Banking in 2016: An exchange on key trends for US banks by Goldman Sachs Exchanges
22 min listen
Billion Dollar Babies: Virtual Reality and the Shift to Cloud: An exchange on virtual reality and the cloud by Goldman Sachs Exchanges
23 min listen
Oil: Lower for Even Longer: An exchange on global commodity markets by Goldman Sachs Exchanges
23 min listen
"Fat and Flat" and the Market Path from Here: An exchange on equity markets by Goldman Sachs Exchanges
27 min listen
The Evolution of the 'Long Good Buy': An exchange on global equity markets by Goldman Sachs Exchanges
20 min listen
Flat is the New Up: An exchange on a new expectations for global markets by Goldman Sachs Exchanges
27 min listen
Whenever, Wherever: The New Model for Retail: An exchange on the consumer retail sector by Goldman Sachs Exchanges
17 min listen

More Episodes from Goldman Sachs Exchanges

Skip carousel

Power surge: AI, renewable energy, and the future of electricity by Goldman Sachs Exchanges
29 min listen
Central bank divergence: Why it's happening and why it matters by Goldman Sachs Exchanges
21 min listen
Can private equity bounce back? by Goldman Sachs Exchanges
27 min listen
Is China’s rebound for real? by Goldman Sachs Exchanges
28 min listen
How AI, the energy transition, and the future of work are shaping impact investing by Goldman Sachs Exchanges
22 min listen
Is the UK economy finally turning the corner? by Goldman Sachs Exchanges
22 min listen
Why Treasury auctions — and rising deficits — are becoming a focal point for markets and investors by Goldman Sachs Exchanges
23 min listen
Weighing the GLP-1 Market by Goldman Sachs Exchanges
24 min listen
Are inflation fears overblown? The outlook for inflation, US growth, and long-term rates by Goldman Sachs Exchanges
22 min listen
Global insurers turn to private credit — and AI by Goldman Sachs Exchanges
20 min listen
Capital Group’s Rob Lovelace on long-term investing, succession planning, and leadership lessons by Goldman Sachs Exchanges
43 min listen
Are the largest US stocks too dominant? by Goldman Sachs Exchanges
19 min listen
Global transit & trade: in rough waters by Goldman Sachs Exchanges
33 min listen
High mortgage rates, limited inventory continue to challenge the US housing market by Goldman Sachs Exchanges
21 min listen
What’s ahead for retail: how retail CEOs are navigating a more complex environment by Goldman Sachs Exchanges
37 min listen
Beyond roads, bridges, and tunnels: the megatrends shaping infrastructure investments by Goldman Sachs Exchanges
24 min listen
Dimensional’s Founder and Chairman David Booth on being an index pioneer, working with Nobel laureates, and investing through uncertainty by Goldman Sachs Exchanges
36 min listen
Shifting supply and demand dynamics buffer oil market by Goldman Sachs Exchanges
21 min listen
2024: the year of elections by Goldman Sachs Exchanges
26 min listen
Investing in a post-modern ‘super cycle’ by Goldman Sachs Exchanges
23 min listen
The Future of Four Wheels: Episode 4, How a New Kind of Car Will Change Our World by Goldman Sachs Exchanges
29 min listen
The Future of Four Wheels: Episode 3, The New New-Car Business by Goldman Sachs Exchanges
35 min listen
The Future of Four Wheels: Episode 2, Building the Car of the Future by Goldman Sachs Exchanges
29 min listen
The Future of Four Wheels: Episode 1, The Twin Revolution by Goldman Sachs Exchanges
26 min listen
Goldman Sachs Chairman and CEO David Solomon on the global economy, the deal-making environment, and the firm’s strategic priorities by Goldman Sachs Exchanges
20 min listen
America Powers On: Why US equities are still poised to outperform in 2024 by Goldman Sachs Exchanges
22 min listen
US presidential elections outlook: Implications for policy and markets by Goldman Sachs Exchanges
27 min listen
KKR’s Henry Kravis on private equity, culture, and global markets by Goldman Sachs Exchanges
54 min listen
Uncharted territory: Navigating a ‘geopolitical recession’ by Goldman Sachs Exchanges
35 min listen
Asset allocation outlook: The case for greater portfolio diversification in 2024 by Goldman Sachs Exchanges
33 min listen

Related podcast episodes

Skip carousel

Economist Argues Maximizing Shareholder Value Hurts Drug Innovation: The pharmaceutical industry has long argued that high drug prices are necessary to incentivize investment in and fund high-risk research and development of innovative new therapies. In a working paper published by the Institute for New Economic Think... by The Bio Report
36 min listen
The iterative nature of emerging therapeutics: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jennifer Chadwick, CSO of ProtaGene. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Je... by Molecule to Market: Inside the outsourcing space
51 min listen
S01 Ep06 with Rob Scott: What are a Clinician’s Priorities for Data-Driven Medicine?: Rob Scott, Chief Medical Officer at AbbVie, discusses the importance of a clinician’s perspective for keeping clinical trial development focussed on the patients. Rob talks about how the role of a Chief Medical Officer changes between a large pharma comp... by Data & Science with Glen Wright Colopy
27 min listen
Built in Boston, now rebuilding businesses: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Michael Kallelis, Chief Executive Officer at Mikart. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology suppl... by Molecule to Market: Inside the outsourcing space
46 min listen
54. Money, Molecules, and Mind-Benders: Seth Yakatan Returns, Nuff Said by Grow Everything Biotech Podcast
76 min listen
Inside the New Hybrid Roles for Cell Therapy Clinical Trials with Immatics' Michael Mehler by Cell & Gene: The Podcast
24 min listen
Investing in a post-modern ‘super cycle’ by Goldman Sachs Exchanges
23 min listen
Richard Scheller (Genentech) - Developing Products that Save Lives by Entrepreneurial Thought Leaders
60 min listen
Prognostic significance of splicing factor gene mutations in AML; therapy resistance in multiple myeloma; the effects of KIT ligand deletion on HSC homeostasis by Blood Podcast
20 min listen
Health Section: Great Unwinding: Join host Jackie Lee and guest Colby Schaeffer as they delve into the recent SOA research paper, “.” They explore the model presented in the research paper and discuss the societal and actuarial implications of the Great Unwinding. Tune in to... by SOA Podcasts - Society of Actuaries
23 min listen
In the trenches of pharma manufacturing: In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ray Kaczmarek, Chief Executive Officer at Genezen. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply ch... by Molecule to Market: Inside the outsourcing space
55 min listen
The Changing Biotech Business and Big Data Ecosystem - Dr. Jeffrey Reid, Regeneron by Talking Biotech with Dr. Kevin Folta
42 min listen
What the Fed’s Hawkish Pivot Means for Economic Growth and Markets by Goldman Sachs Exchanges
25 min listen
Moving from Chronic Therapies to Cures: The rapidly growing area of regenerative medicine is promising to replace chronic therapies with cures. As the biotechnology industry gathers in San Francisco for a big week of meetings, the Alliance for Regenerative Medicine is readying to deliver i... by The Bio Report
22 min listen
MedTech Investing with Paul LaViolette of SV Health Investors and Jonathan P. Gertler, MD, Back Bay Life Science Advisors and BioVentures Medtech Funds: Join the conversation between Paul LaViolette, SV Health Investors and Jonathan P. Gertler, MD, Back Bay Life Science Advisors and BioVentures Medtech Funds For years, biotech has been the dominant theme in life sciences development, offering a great d by Back Bay Life Science Report
27 min listen
The High Cost of Multiple Sclerosis: The High Cost of Multiple Sclerosis by Neurology Minute
3 min listen
Investing in Longbio True Believers (Sebastian Brunemeier, Healthspan Capital & ImmuneAge Pharma) by Translating Aging
44 min listen
Immunotherapies ETF Lets Biotech Investors Bet on Emerging Sector: A new class of immunotherapies is promising to radically alter the treatment of cancers and has generated excitement among investors for their groundbreaking potential. Now the Loncar Cancer Immunotherapy ETF provides a way for investors to bet on t... by The Bio Report
21 min listen
Enabling Precision Medicine through Proteomics: While the revolution in genomics has led to rapid improvements in the cost and speed of sequencing and created new insights into the genetic drivers of health and wellness, proteomics has lagged behind. Being able to capture a comprehensive view of t... by The Bio Report
37 min listen
How biosimilars are affecting the drug markets: Listen to Health Affairs Editor-in-Chief Alan Weil interview Ariel Dora Stern from Harvard Business School on what biosimilars are and how the pharmaceutical market is evolving in response to their market entry. by A Health Podyssey
27 min listen
Unfair Criticisms of Psychopharmacology: A recently published book provides sharp criticism of the modern era of clinical psychopharmacology, questioning the validity of psychiatric diagnoses and the effectiveness of psychopharmacologic treatments. In this podcast, Dr. Anthony J. Rothschild,... by The Journal of Clinical Psychopharmacology Podcast
7 min listen
How Glympse Bio oversubscribed their Series B funding amidst the pandemic by Conversations in Healthcare
44 min listen
Episode 95 by Biotech Hangout
61 min listen
Enhance Stem Cell Activation Naturally – Christian Drapeau : 1165 by The Human Upgrade with Dave Asprey
16 min listen
Episode 101 by Biotech Hangout
60 min listen
Episode: 50 - Pivoting Research with Antibody Drug Conjugates by The Chain: Protein Engineering Podcast
31 min listen
Cannabis & Biotech. Nuff Said. by Grow Everything Biotech Podcast
73 min listen
Mini Episode: Enhance Stem Cell Activation Through Hyperbarics - Dr. Allen Meglin : 1163 by The Human Upgrade with Dave Asprey
14 min listen
Title: Pharma and Biotech Daily: Your Source for the Latest Industry Updates by Pharma and BioTech Daily
3 min listen
Ep. 24 - Real Conversations: Richard L. Peterson - How to Successfully Trade Sentiment by Hedgeye Podcasts
32 min listen

Discover this podcast and so much more

Gene Editing: The Future of Genomic Medicine & Biotech Investing

Gene Editing: The Future of Genomic Medicine & Biotech Investing

Description

Titles in the series (100)

More Episodes from Goldman Sachs Exchanges

Related podcast episodes